The Elk-1 and serum response factor binding sites in the major immediate-early promoter of human cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NF-κB sites in proliferating cells

Journal of Virology

Volumn 84, Issue 9, 2010, Pages 4481-4493

  Caposio, Patrizia ^a   Luganini, Anna ^a   Bronzini, Matteo ^a   Landolfo, Santo ^a   Gribaudo, Giorgio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR ELK 1;

ARTICLE; BINDING SITE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; VIRUS RECOMBINANT; VIRUS REPLICATION;

BINDING SITES; CELLS, CULTURED; CYTOMEGALOVIRUS; DNA, VIRAL; ETS-DOMAIN PROTEIN ELK-1; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; NF-KAPPA B; PROMOTER REGIONS, GENETIC; SERUM RESPONSE FACTOR; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5;

EID: 77950855886     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02141-09     Document Type: Article

References (48)

1. Benedict, C. A., A. Angulo, S. Ha, H. Huang, M. Messerle, C. F. Ware, and P. Ghazal. 2004. Neutrality of the canonical NF-κB pathway for human and murine cytomegalovirus transcription and replication in vitro. J. Virol. 78: 741-750.
2. Bissinger, A. L., C. Sinzger, E. Kaiserling, and G. Jahn. 2002. Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J. Med. Virol. 67:200-206.
3. Boldogh, I., S. AbuBakar, C. Z. Deng, and T. Albrecht. 1991. Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus. J. Virol. 65:1568-1571.
4. Boldogh, I., M. P. Fons, and T. Albrecht. 1993. Increased levels of sequence-specific DNA-binding proteins in human cytomegalovirus infected cells. Biochem. Biophys. Res. Commun. 197:1505-1510.
5. Britt, W. 2008. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr. Top. Microbiol. Immunol. 325:417-470.
6. Buchwalter, G., C. Gross, and B. Wasylyk. 2004. Ets ternary complex transcription factors. Gene 324:1-14. (Pubitemid 38030321)
7. Caposio, P., M. Dreano, G. Garotta, G. Gribaudo, and S. Landolfo. 2004. Human cytomegalovirus stimulates IKK2 activity and requires the enzyme for productive replication. J. Virol. 78:3190-3195. (Pubitemid 38314380)
8. Caposio, P., A. Luganini, G. Hahn, S. Landolfo, and G. Gribaudo. 2007. Activation of the virus-induced IKK/NF-κB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells. Cell. Microbiol. 9:2040-2054.
9. Chan, Y. J., C. J. Chiou, Q. Huang, and G. S. Hayward. 1996. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediates both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types. J. Virol. 70:8590-8605.
10. Chen, J., and M. F. Stinski. 2002. Role of regulatory elements and the MAPK/ERK or p38 MAPK pathways for activation of human cytomegalovirus gene expression. J. Virol. 76:4873-4885. (Pubitemid 34441693)
11. DeMeritt, I. B., L. Milford, and A. D. Yurochko. 2004. Activation of the NF-κB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. J. Virol. 78:4498-4507.
12. Favata, M. F., K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, R. A. Copeland, R. L. Magolda, P. A. Scherle, and J. M. Trzaskos. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:18623-18632.
13. Gerna, G., F. Baldanti, M. Zavattoni, A. Sarasini, E. Percivalle, and M. G. Revello. 1992. Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay. Antivir. Res. 19:333-345.
14. Gille, H., M. Kortenjann, O. Thomae, C. Moomaw, C. Slaughter, M. H. Cobb, and P. E. Shaw. 1995. ERK phosphorylation potentiates Elk-1 mediated ternary complex formation and transactivation. EMBO J. 14:951-962.
15. Gustems, M., E. Borst, C. A. Benedict, C. Perez, M. Messerle, P. Ghazal, and A. Angulo. 2006. Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-κB binding sites in the enhancer. J. Virol. 80:9899-9904. (Pubitemid 44435665)
16. Hahn, G., H. Khan, F. Baldanti, U. H. Koszinowski, M. G. Revello, and G. Gerna. 2002. The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics. J. Virol. 76:9551-9555. (Pubitemid 34919913)
17. Isomura, H., T. Tsurumi, and M. F. Stinski. 2004. Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication. J. Virol. 78:12788-12799. (Pubitemid 39507787)
18. Jacqué, J. M., A. Mann, H. Enslen, N. Sharuva, B. Brichacek, R. J. Davis, and M. Stevenson. 1998. Modulation of HIV infectivity by MAPK, a virion-associated kinase. EMBO J. 17:2607-2618.
19. Jarvis, A. M., and J. A. Nelson. 2002. Human cytomegalovirus persistence and latency in endothelial cells and macrophage. Curr. Opin. Microbiol. 5:403-407.
20. Johnson, R. A., S.-M. Huong, and E.-S. Huang. 2000. Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. J. Virol. 74:1158-1167.
21. Johnson, R. A., X. L. Ma, A. D. Yurochko, and E. S. Huang. 2001. The role of MKK1/2 kinase activity in human cytomegalovirus infection. J. Gen. Virol. 82:493-497.
22. Keller, M. J., D. G. Wheeler, E. Cooper, and J. L. Meier. 2003. Role of the human cytomegalovirus major immediate-early promoter's 19-based-pair-repeat cAMP response element in acutely infected cells. J. Virol. 77:6666-6675.
23. Landolfo, S., M. Gariglio, G. Gribaudo, and D. Lembo. 2003. The human cytomegalovirus. Pharmacol. Ther. 98:269-297.
24. Lashmit, P., S. Wang, H. Li, H. Isomura, and M. F. Stinski. 2009. The CREB site in the proximal enhancer is critical for cooperative interaction with the other transcription factor binding sites to enhance transcription of the MIE early genes in human cytomegalovirus infected cells. J. Virol. 83:8893-8904.
25. Martin, P., W. C. Vass, J. T. Schiller, D. R. Lowry, and T. J. Velu. 1989. The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF receptors. Cell 59:21-32. (Pubitemid 19248555)
26. Martín-Blanco, E. 2000. p38 MAPK signaling cascades: ancient roles and new functions. BioEssays 22:637-645. (Pubitemid 30457955)
27. Meier, J. L., and J. A. Pruessner. 2000. The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early expression. J. Virol. 74:1602-1613.
28. Meier, J. L., and M. F. Stinski. Major immediate-early enhancer and its gene products, p. 151-156. In M. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, London, United Kingdom.
29. Mocarski, E. S., Jr., T. Shenk, and R. F. Pass. 2006. Cytomegaloviruses, p. 2701-2772. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
30. Oikawa, T., and T. Yamada. 2003. Molecular biology of the Ets family of transcription factors. Gene 303:11-34. (Pubitemid 36151767)
31. Price, M. A., F. H. Cruzalegui, and R. Treisman. 1996. The p38 and ERK MAP kinase pathways cooperate to activate ternary complex factors and c-fos transcription in response to UV light. EMBO J. 15:6552-6563.
32. Revello, M. G., F. Baldanti, E. Percivalle, A. Sarasini, L. De Giuli, E. Genini, D. Lilleri, N. Labo, and G. Gerna. 2001. In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. J. Gen. Virol. 82:1429-1438.
33. Robinson, M. J., and M. H. Cobb. 1997. Mitogen-activated protein kinase pathway. Curr. Opin. Cell Biol. 9:180-186.
34. Sambucetti, L. C., J. M. Cherrington, G. W. Wilkinson, and E. S. Mocarski. 1989. NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 8:4251-4258.
35. Seger, R., and E. G. Krebs. 1995. The MAPK signaling cascade. FASEB J. 9:726-734.
36. Sharrocks, A. D. 2002. Complexities in ETS-domain transcription factor function and regulation: lessons from TCF (ternary complex factor) subfamily. Biochem. Soc. Trans. 30:1-9.
37. Sinclair, J. 12 August 2009, posting date. Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection. Biochim. Biophys. Acta [Epub ahead of print.] doi:10.1016/j.bbagrm. 2009.08.001.
38. Sinzger, C., A. Grefte, B. Plachter, A. S. H. Gouw, T. H. The, and G. Jahn. 1995. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are the major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J. Gen. Virol. 76:741-750.
39. Singzer, C., M. Digel, and G. Jahn. 2008. Cytomegalovirus cell tropism. Curr. Top. Microbiol. Immunol. 325:63-83.
40. Sontag, E., S. Fedorov, C. Kamibayashi, D. Robbins, M. Cobb, and M. Mumby. 1993. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates MAP kinase pathway and induces cell proliferation. Cell 75:887-897. (Pubitemid 24014546)
41. Stinski, M. F., and H. Isomura. 2008. Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency. Med. Microbiol. Immunol. 197:223-231.
42. Stinski, M. F., and D. T. Petrick. 2008. Functional roles of the human cytomegalovirus essential IE86 protein. Curr. Top. Microbiol. Immunol. 325:133-152.
43. Treisman, R. 1986. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 46:567-574. (Pubitemid 16022411)
44. Warming, S., N. Costantino, D. L. Court, N. A. Jenkins, and N. G. Copeland. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33:e36.
45. Wei, L., and J. Liu. 2009. Porcine circovirus type 2 replication is impaired by inhibition of extracellular-regulated kinase (ERK) signaling pathway. Virology 386:203-209.
46. Widmann, C., S. Gibson, M. B. Jarpe, and G. L. Johnson. 1999. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79:236-244.
47. Yang, S.-H., and A. D. Sharrocks. 2006. Convergence of the SUMO and MAPK pathways on the ETS-domain transcription factor Elk-1. Biochem. Soc. Symp. 73:121-129.
48. Yurochko, A. D. 2008. Human cytomegalovirus modulation of signal transduction. Curr. Top. Microbiol. Immunol. 325:205-220.